Conference Reports for NATAP

EASL - The International Liver Congress 2014 49th Annual Meeting of the European Association for the Study of the Liver London, United Kingdom  April 9-13 Back

Tweet

HCV in India at EASL: IDUs, Burden, Limited Access       EASL: High Burden of HCV & HIV/HCV Coinfection among Injection Drug Users in India: Need for Integration of HIV & HCV Services - (04/28/14)   EASL: High Burden of Fibrosis and Metabolic Cofactors in a Cohort of Predominantly Genotype 3-Infected Injection Drug Users in Southern India - (05/01/14)   EASL: Limited Access to HCV Testing and Treatment among Injection Drug Users across India - (04/30/14)   EASL - The International Liver Congress 2014 49th Annual Meeting of the European Association for the Study of the Liver London, United Kingdom April 9-13